[go: up one dir, main page]

DE69835536D1 - Zusammensetzungen zur behandlung von staphylococcus aureus infektionen - Google Patents

Zusammensetzungen zur behandlung von staphylococcus aureus infektionen

Info

Publication number
DE69835536D1
DE69835536D1 DE69835536T DE69835536T DE69835536D1 DE 69835536 D1 DE69835536 D1 DE 69835536D1 DE 69835536 T DE69835536 T DE 69835536T DE 69835536 T DE69835536 T DE 69835536T DE 69835536 D1 DE69835536 D1 DE 69835536D1
Authority
DE
Germany
Prior art keywords
compositions
treatment
staphylococcus aureus
aureus infections
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69835536T
Other languages
English (en)
Other versions
DE69835536T2 (de
Inventor
Naomi Balaban
W Larrick
C Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69835536D1 publication Critical patent/DE69835536D1/de
Application granted granted Critical
Publication of DE69835536T2 publication Critical patent/DE69835536T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69835536T 1997-12-19 1998-12-18 Zusammensetzungen zur behandlung von staphylococcus aureus infektionen Expired - Lifetime DE69835536T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6809497P 1997-12-19 1997-12-19
US68094P 1997-12-19
US54331 1998-04-02
US09/054,331 US6291431B1 (en) 1997-12-19 1998-04-02 Methods and compositions for the treatment and prevention of Staphylococcal infections
PCT/US1998/027091 WO1999032133A1 (en) 1997-12-19 1998-12-18 Methods and compositions for the treatment and prevention of staphylococcus aureus infections

Publications (2)

Publication Number Publication Date
DE69835536D1 true DE69835536D1 (de) 2006-09-21
DE69835536T2 DE69835536T2 (de) 2007-08-09

Family

ID=26732900

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835536T Expired - Lifetime DE69835536T2 (de) 1997-12-19 1998-12-18 Zusammensetzungen zur behandlung von staphylococcus aureus infektionen

Country Status (10)

Country Link
US (2) US6291431B1 (de)
EP (1) EP1037650B1 (de)
AT (1) ATE335499T1 (de)
AU (1) AU2005099A (de)
CY (1) CY1106234T1 (de)
DE (1) DE69835536T2 (de)
DK (1) DK1037650T3 (de)
ES (1) ES2270540T3 (de)
PT (1) PT1037650E (de)
WO (1) WO1999032133A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703374B1 (en) 1997-10-30 2004-03-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleosides for imaging and treatment applications
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
US7323179B2 (en) * 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US7534857B2 (en) * 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
US20080219976A1 (en) * 1997-12-19 2008-09-11 Naomi Balaban Methods and compositions for treatment and prevention of staphylococcal infections
EP1188831B1 (de) * 1998-09-15 2007-12-05 Naomi Balaban Ziel des RNAIII activierenden Proteines (TRAP)
EP1862549A3 (de) * 1998-09-15 2008-02-13 Naomi Balaban Target eines RNAIII-aktivierenden Proteins (TRAP)
US20030050248A1 (en) * 2000-02-10 2003-03-13 Wright Susan C. Novel amino acid and peptide inhibitors of Staphylococcus virulence
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
CN1569889A (zh) * 2003-07-21 2005-01-26 中国人民解放军军事医学科学院基础医学研究所 能与金葡菌自分泌的rnaiii激活蛋白结合的环多肽及其医药用途
EP1621203A1 (de) * 2004-07-27 2006-02-01 Genoscience RNAIII-inhibierende Peptide für die Behandlung von HIV-Infektion
US20070009566A1 (en) * 2005-04-04 2007-01-11 Naomi Balaban Method and apparatus for treating bacterial infections in devices
US20070092572A1 (en) * 2005-04-04 2007-04-26 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US20070015685A1 (en) * 2005-04-04 2007-01-18 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US7824691B2 (en) * 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
EP1906985A4 (de) * 2005-05-10 2012-07-11 Naomi Balaban Zusammensetzungen zur verabreichung von rnaiii-hemmenden peptiden
JP2009523704A (ja) 2005-11-18 2009-06-25 グランビア ニュートリショナルズ （アイルランド） リミテッド 創傷バイオフィルムを破壊する、および創傷バイオフィルム再構成を阻害するための組成物
WO2007090123A2 (en) * 2006-01-30 2007-08-09 University Of Chicago Mgra is a redox regulator of antibiotic sensitivity and virulence
US20070293435A1 (en) * 2006-06-16 2007-12-20 Naomi Balaban Identification and Use of Non-Peptide Analogs of RNAIII-Inhibiting Peptide for the Treatment of Staphylococcal Infections
CA2684570A1 (en) 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
EP2872535A1 (de) 2012-07-16 2015-05-20 Pfizer Inc. Saccharide und verwendungen davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3043362B2 (ja) 1989-04-27 2000-05-22 マクニール―ピーピーシー・インコーポレーテツド タンポンへの添加剤
WO1996010579A1 (en) 1994-10-04 1996-04-11 New York University Blocking expression of virulence factors in s. aureus
JP2000511537A (ja) 1996-05-22 2000-09-05 ニューヨーク・ユニヴァーシティ 黄色ブドウ球菌における毒力因子の発現の阻止
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections

Also Published As

Publication number Publication date
ES2270540T3 (es) 2007-04-01
EP1037650A4 (de) 2004-10-20
US20040077534A1 (en) 2004-04-22
AU2005099A (en) 1999-07-12
CY1106234T1 (el) 2011-06-08
US6291431B1 (en) 2001-09-18
EP1037650A1 (de) 2000-09-27
US7067135B2 (en) 2006-06-27
ATE335499T1 (de) 2006-09-15
WO1999032133A1 (en) 1999-07-01
PT1037650E (pt) 2006-12-29
DE69835536T2 (de) 2007-08-09
DK1037650T3 (da) 2006-12-11
EP1037650B1 (de) 2006-08-09

Similar Documents

Publication Publication Date Title
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DE69934010D1 (de) Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
PT920421E (pt) Derivados de isoxazolina uteis como agentes antimicrobianos
PT1077718E (pt) Melhoramentos da actividade de agentes antibacterianos de oxazolidinona por derivados de arginina
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
DE69825128D1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
ATE225172T1 (de) Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
DE69935662D1 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
DE60134881D1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen
ATE446755T1 (de) Antihelmintika zur verhinderung von parasitären infektionen bei mensch und tier
ATE279195T1 (de) Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iii
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций

Legal Events

Date Code Title Description
8364 No opposition during term of opposition